查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565721

临床前 CRO 市场，按服务、按模型类型、按最终用途、按国家和地区划分：2024 年至 2032 年的行业分析、市场规模、市场份额和预测

Preclinical CRO Market, By Service, By Model Type, By End Uses, By Country, and By Region: Industry Analysis, Market Size, Market Share, and Forecast from 2024 to 2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年临床前 CRO 市场规模预估为 57.542 亿美元，2024 年至 2032 年复合年增长率为 8.90%。

临床前CRO市场-市场动态

透过外包服务临床前 CRO 市场成长激增

对外包服务的需求不断增长预计将推动临床前 CRO 市场的未来成长。外包服务是与第三方提供者签订合约来处理特定业务任务或营运的做法。临床前研究变得越来越复杂，需要专业技能和经验，但并非所有製药和生技公司都拥有内部技能和经验。外包给临床前 CRO 使企业能够获得所需的知识，而无需投资于能力开发，使他们能够在进行临床前研究的同时专注于核心业务。例如，根据美国独立策略资讯和分析提供者BioPlan Associates Inc. 对207 名生物製药受访者和138 家供应商进行的调查，2023 年4 月，约84.6% 的生物製造商外包分析测试，74.5%外包毒性测试因此，对外包服务的需求不断增长正在推动临床前 CRO 市场的发展。

临床前 CRO 市场 - 关键见解

我们的研究分析师预测 2024 年至 2032 年全球市场的复合年增长率为 8.90%。

根据服务细分研究，到 2023 年，毒理学测试类别将占据全球临床前 CRO 市场的最大收入份额。

2023 年，按模型类型细分，患者衍生类器官 (PDO) 模型领域在全球临床前 CRO 市场中占据主导地位。

按地区划分，北美地区 2023 年收入最高。

临床前 CRO 市场細項分析：

全球临床前 CRO 市场分为四组：服务、模型类型、最终用途和地理位置。

根据服务，市场分为六个部分：毒理学测试、生物分析和 DMPK 研究、化学、化合物管理、安全药理学等。 2023年，由于非核心临床前CRO研究外包的增加以及毒理学测试的广泛使用，毒理学测试类别在全球临床前CRO市场中占据最高的收入份额。由于 CRO 进行毒理学测试的能力增强，毒理学是外包给 CRO 的主要服务之一。将非核心临床前研究外包给 CRO 的比例不断增加，以及 CRO 提供额外增值服务的能力不断增强，可能会在预测期内推动这一类别的扩张。

根据模型类型，市场分为两个部分：患者来源的类器官（PDO）模型和患者来源的异种移植模型。 2023 年，患者衍生类器官 (PDO) 模型细分市场占有最大市场份额。由于利用直接源自患者的细胞和组织，患者来源的类器官（PDO）模型越来越受欢迎。这有助于个人化医疗保健，并且可以冷冻保存标本。由于这些原因，它们正在成为临床前研究的一个重要方面，因为它们有助于更快地检测和预后癌症。

临床前 CRO 市场 - 地理洞察

市场地理多元化，遍及欧洲、中东、北美、亚太地区、非洲、拉丁美洲。这些地区被带来商业的国家进一步划分。

北美地区在 2023 年的比例最高，因为存在专注于早期药物发现的成熟 CRO，例如 Charles River Laboratories 和 LabCorp。美国是最大的临床前试验外包市场，一些生物製药公司更愿意将其临床前试验外包给位于美国的 CRO，以便从 FDA 批准的研究性新药 (IND) 申请中受益。

同样预期亚太地区在预测期内将以最快的速度成长。由于跨国公司外包业务模式的转变和研发成本的上升，以及印度和中国等国家 CRO 提供的成本效率，亚太地区的临床前外包预计将扩大。来自西欧和美国的老牌公司在亚太地区寻求分析服务、现场研究开发和临床活动，以降低研究成本。

临床前CRO市场-竞争格局：

临床前合约研究组织 (CRO) 市场的竞争高度多元化，大型公司和新兴企业都在其临床前服务平台上运作。市场上的主要参与者包括 Eurofins Scientific、LABCOR、PRA Health Sciences, Inc. 等。科文斯拥有出色的临床前产品组合服务范围，并且在药物开发方面拥有丰富的经验。该领域的主要参与者包括药明康德（WuXi AppTec）和PPD（PPD），前者提供所有药物开发过程的整合解决方案，后者以其全球影响力和能力而闻名。规模较小的 CRO 也不断涌现，它们针对自己擅长的特定治疗领域，进一步推动了临床前研究，加剧了竞争。

最新进展：

2023 年 3 月，Crown Bioscience 和 JSR 生命科学公司宣布在新加坡开设新工厂，这将帮助该公司提高为本地和全球生物技术和製药公司提供服务的能力。该网站将帮助参与临床前和转化肿瘤药物研究和开发的公司。

目录

第一章：临床前 CRO 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按服务分類的临床前 CRO 市场片段
    • 按模型类型分類的临床前 CRO 市场片段
    • 按最终用途分類的临床前 CRO 市场片段
    • 按国家/地区分類的临床前 CRO 市场片段
    • 按地区分類的临床前 CRO 市场片段
  • 竞争洞察

第 3 章：临床前 CRO 主要市场趋势

  • 临床前 CRO 市场驱动因素
    • 市场驱动因素的影响分析
  • 临床前CRO市场限制
    • 市场限制影响分析
  • 临床前CRO市场机会
  • 临床前CRO市场未来趋势

第 4 章：临床前 CRO 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：临床前 CRO 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：临床前 CRO 市场格局

  • 2023 年临床前 CRO 市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：临床前 CRO 市场 - 按服务分类

  • 概述
    • 按服务分類的细分市场占有率分析
    • 毒理学测试
    • 生物分析和 DMPK 研究
    • 化学
    • 化合物管理
    • 安全药理学
    • 其他的

第 8 章：临床前 CRO 市场 - 按模型类型

  • 概述
    • 按车型类型分類的细分市场份额分析
    • 患者来源的类器官 (PDO) 模型
    • 患者来源的异种移植模型

第 9 章：临床前 CRO 市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医疗器材公司
    • 生物製药
    • 政府及学术机构

第 10 章：临床前 CRO 市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美临床前CRO主要生产商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按服务）
    • 北美市场规模和预测（按车型类型）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲临床前CRO主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按服务）
    • 欧洲市场规模和预测（按车型类型）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区临床前CRO主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按服务）
    • 亚太地区市场规模和预测（按型号类型）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲临床前CRO主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按服务）
    • 拉丁美洲市场规模与预测（按车型类型）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲临床前CRO主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按服务）
    • 中东和非洲市场规模及预测（按车型类型）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 临床前 CRO 产业

  • 竞争仪表板
  • 公司简介
    • Eurofins Scientific
    • LABCORP
    • PRA Health Sciences, Inc.
    • Wuxi AppTec
    • Medpace, Inc.
    • PPD (Thermo Fisher Scientific, Inc.)
    • Charles River Laboratories International, Inc.
    • SGA SA
    • Intertek Group Plc (IGP)
    • Crown Bioscience
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3904

REPORT HIGHLIGHT

Preclinical CRO Market size was evaluated at USD 5,754.2 million in 2023, rising at a CAGR of 8.90% between 2024 and 2032.

Preclinical CROs (contract research organizations) are support organizations that provide the knowledge in research and development required to guide a drug candidate through animal testing and into clinical trials. A preclinical CRO helps innovative medical product producers demonstrate safety and efficacy in animals that closely resemble human anatomy before entering clinical trials or being employed in human care.

Preclinical CRO Market- Market Dynamics

Surge In Preclinical CRO Market Growth Through Outsourcing Services

Growing demand for outsourcing services is projected to drive future growth in the preclinical CRO market. Outsourcing services is the practice of contracting with a third-party provider to handle specific business tasks or operations. Preclinical research is getting more sophisticated, necessitating specialized skills and experience that not all pharmaceutical and biotechnology companies possess in-house. Outsourcing to preclinical CROs enables businesses to gain access to the knowledge they require without investing in capability development, allowing them to focus on core business while still conducting preclinical research. For instance, according to a survey of 207 biopharma respondents and 138 suppliers conducted by BioPlan Associates Inc., a US-based provider of independent strategic information and analysis, approximately 84.6% of biomanufacturers outsource analytical testing and 74.5% outsource toxicity testing in April 2023. As a result, increasing demand for outsourcing services is propelling the preclinical CRO market forward.

Preclinical CRO Market- Key Insights

Our research analyst predicts an 8.90% CAGR for the global market from 2024 to 2032.

In 2023, In 2023, the toxicology testing category accounted for the biggest revenue share of the worldwide preclinical CRO market, according to Service segmentation research.

In 2023, the Patient Derived Organoid (PDO) model sector dominated the worldwide Preclinical CRO market by Model Type segmentation.

According to region, North America had the most revenue in 2023.

Preclinical CRO Market- Segmentation Analysis:

The global Preclinical CRO Market is divided into four groups: Service, Model Type, End Uses, and geography.

The market is segmented into six divisions based on the Service: Toxicology Testing, Bioanalysis & DMPK Studies, Chemistry, Compound Management, Safety Pharmacology, and Others. In 2023, the toxicology testing category had the highest revenue share of the worldwide preclinical CRO market, owing to increased outsourcing of noncore preclinical CRO studies and widespread utilization of toxicology tests. toxicology is one of the primary services being outsourced to CROs due to their enhanced ability to conduct toxicological tests. The increasing rate of outsourcing noncore preclinical investigations to CROs, as well as CROs' rising ability to provide additional value-added services, are likely to drive expansion in this category during the projection period.

The market is classified into two segments depending on the Model Type: The patient-Derived Organoid (PDO) Model and the Patient-derived xenograft model. In 2023, the Patient-Derived Organoid (PDO) Model segment had the most market share. The patient-derived organoid (PDO) model is gaining popularity due to the utilization of directly derived cells and tissues from the patient. This aids in individualized healthcare, and specimens can be cryopreserved. For these reasons, they are becoming an important aspect of preclinical investigations since they aid in the faster detection and prognosis of cancer.

Preclinical CRO Market- Geographical Insights

This market is geographically diversified across Europe, the Middle East, North America, Asia Pacific, and Africa, Latin America. The regions are further divided by the nations that bring commerce.

North America had the highest proportion in 2023 because to the presence of established CROs focusing in early drug discovery, such as Charles River Laboratories and LabCorp. The United States is the largest market for preclinical trial outsourcing, as several biopharmaceutical companies prefer to outsource their preclinical trials to CROs situated in the United States in order to benefit from FDA-approved Investigational New Drug (IND) applications.

Asia Pacific is likewise expected to increase at the quickest rate over the projection period. Preclinical outsourcing in Asia Pacific is predicted to expand because to the shifting business model of MNC outsourcing and rising R&D costs, as well as the cost efficiency offered by CROs in countries such as India and China. Established corporations from Western Europe and the United States pursue analytical services, site research development, and clinical activities in the Asia Pacific region to cut research costs.

Preclinical CRO Market- Competitive Landscape:

The Preclinical Contract Research Organization (CRO) Market is highly diversified concerning the competition, with both large companies and emerging players operating with their preclinical services platforms. The key profiled players in the market are Eurofins Scientific, LABCOR, PRA Health Sciences, Inc., and others. It features an excellent preclinical portfolio service range, and Covance boasts vast experience in drug development. Major players in this space include WuXi AppTec, which offers the integrated solutions of all the drugs' development process, and PPD, known for its global reach and capabilities. Smaller niche CROs are also emerging that target specific therapeutic areas where they have their specialties, further fueling preclinical research with a thus intensified competition.

Recent Developments:

In March 2023, Crown Bioscience and JSR Life Sciences Company have announced the opening of a new location in Singapore, which will help the company increase its capacity for local and worldwide biotech and pharmaceutical companies. The website will help companies involved in preclinical and translational oncology medication research and development.

SCOPE OF THE REPORT

This report's scope includes the following important market segments:

GLOBAL PRECLINICAL CRO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Eurofins Scientific
  • LABCORP
  • PRA Health Sciences, Inc.
  • Wuxi AppTec
  • Medpace, Inc.
  • PPD (Thermo Fisher Scientific, Inc.)
  • Charles River Laboratories International, Inc.
  • SGA SA
  • Intertek Group Plc (IGP)
  • Crown Bioscience
  • Others

GLOBAL PRECLINICAL CRO MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • Toxicology Testing
  • Bioanalysis & DMPK Studies
  • Chemistry
  • Compound Management
  • Safety Pharmacology
  • Others

GLOBAL PRECLINICAL CRO MARKET, BY MODEL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Patient-Derived Organoid (PDO) Model
  • Patient-derived xenograft model

GLOBAL PRECLINICAL CRO MARKET, BY END-USES- MARKET ANALYSIS, 2019 - 2032

  • Medical Device Companies
  • Biopharmaceutical
  • Government & Academic Institutes

GLOBAL PRECLINICAL CRO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preclinical CRO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preclinical CRO Market Snippet by Service
    • 2.1.2. Preclinical CRO Market Snippet by Model Type
    • 2.1.3. Preclinical CRO Market Snippet by End Uses
    • 2.1.4. Preclinical CRO Market Snippet by Country
    • 2.1.5. Preclinical CRO Market Snippet by Region
  • 2.2. Competitive Insights

3. Preclinical CRO Key Market Trends

  • 3.1. Preclinical CRO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preclinical CRO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preclinical CRO Market Opportunities
  • 3.4. Preclinical CRO Market Future Trends

4. Preclinical CRO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preclinical CRO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Preclinical CRO Market Landscape

  • 6.1. Preclinical CRO Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preclinical CRO Market - By Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service, 2023 & 2032 (%)
    • 7.1.2. Toxicology Testing
    • 7.1.3. Bioanalysis & DMPK Studies
    • 7.1.4. Chemistry
    • 7.1.5. Compound Management
    • 7.1.6. Safety Pharmacology
    • 7.1.7. Others

8. Preclinical CRO Market - By Model Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Model Type, 2023 & 2032 (%)
    • 8.1.2. Patient-Derived Organoid (PDO) Model
    • 8.1.3. Patient-derived xenograft model

9. Preclinical CRO Market - By End Uses

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Uses, 2023 & 2032 (%)
    • 9.1.2. Medical Device Companies
    • 9.1.3. Biopharmaceutical
    • 9.1.4. Government & Academic Institutes

10. Preclinical CRO Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Preclinical CRO Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Preclinical CRO Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Preclinical CRO Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Preclinical CRO Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Preclinical CRO Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Preclinical CRO Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eurofins Scientific
    • 11.2.2. LABCORP
    • 11.2.3. PRA Health Sciences, Inc.
    • 11.2.4. Wuxi AppTec
    • 11.2.5. Medpace, Inc.
    • 11.2.6. PPD (Thermo Fisher Scientific, Inc.)
    • 11.2.7. Charles River Laboratories International, Inc.
    • 11.2.8. SGA SA
    • 11.2.9. Intertek Group Plc (IGP)
    • 11.2.10. Crown Bioscience
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us